Sanoma Oyj (0JLQ)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 10.81 |
|---|---|
| 52-week range | 6.92 – 10.81 |
| Return, 1 month / 3 months | +11.4% / +25.0% |
| Return, 1 year / 3 years | +1.7% / +82.4% |
| Trend | Uptrend |
| RSI (14) | 81 |
| Volatility (1 year) | 20.6% |
| Worst drawdown (1 year) | -21.6% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 3.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sanoma Oyj is a Finnish media and learning company based in Helsinki. It publishes magazines and newspapers and runs digital media services for consumers and advertisers. Its learning business provides educational materials, digital platforms and related services to schools and teachers, mainly in European markets. The company also offers marketing and event services, and its media brands reach readers and audiences across Finland and neighbouring countries.
On this site Sanoma Oyj appears as a stock on the London Exchange (UK), code 0JLQ, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sanoma Oyj (0JLQ) trades on the London Exchange in UK. It last closed at EUR 10.81 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 765 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.7% and over the last three months it rose 25.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.8% | ||
| From 52-week high | 0.0% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 25.0% | ||
| 6-month return | 20.4% | ||
| 12-month return, skipping the last month | -8.7% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.6% | ||
| Liquidity | 10 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 75.0% | ||
| Income | 81 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.8% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | +11.4% |
| 3 months | +25.0% |
| 6 months | +20.4% |
| 1 year | +1.7% |
| 3 years | +82.4% |
| 5 years | −7.9% |
Signals
| 50-day / 200-day average | 9.68 / 9.10 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.61 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | EUR 0.1400 |
| 8 May 2026 | EUR 0.1400 |
| 3 Nov 2025 | EUR 0.1300 |
| 15 Sep 2025 | EUR 0.1300 |
| 30 Apr 2025 | EUR 0.1300 |
| 4 Nov 2024 | EUR 0.1100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.